Looking for a Beam of Light to Heal Chronic Pain
Jialing Xu,Hao Zhang,Dan Chen,Kaiyong Xu,Zifa Li,Hongyun Wu,Xiwen Geng,Xia Wei,Jibiao Wu,Wenqiang Cui,Sheng Wei
DOI: https://doi.org/10.2147/jpr.s455549
IF: 2.8319
2024-03-16
Journal of Pain Research
Abstract:Jialing Xu, 1, 2 Hao Zhang, 1, 2 Dan Chen, 2 Kaiyong Xu, 1, 2 Zifa Li, 1, 2 Hongyun Wu, 3 Xiwen Geng, 1, 2 Xia Wei, 4 Jibiao Wu, 1, 2 Wenqiang Cui, 3 Sheng Wei 1, 2 1 The Key Laboratory of Traditional Chinese Medicine Classic Theory of Ministry of Education, Shandong University of Traditional Chinese Medicine, Ji'nan, Shandong, People's Republic of China; 2 Chinese Medicine and Brain Science Interdisciplinary Research Institute, Shandong University of Traditional Chinese Medicine, Ji'nan, Shandong, People's Republic of China; 3 Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, Shandong, People's Republic of China; 4 NMPA Key Laboratory for Research and Evaluation of Generic Drugs, Shandong Institute for Food and Drug Control, Ji'nan, Shandong, People's Republic of China Correspondence: Sheng Wei, Email ; Wenqiang Cui, Email Chronic pain (CP) is a leading cause of disability and a potential factor that affects biological processes, family relationships, and self-esteem of patients. However, the need for treatment of CP is presently unmet. Current methods of pain management involve the use of drugs, but there are different degrees of concerning side effects. At present, the potential mechanisms underlying CP are not completely clear. As research progresses and novel therapeutic approaches are developed, the shortcomings of current pain treatment methods may be overcome. In this review, we discuss the retinal photoreceptors and brain regions associated with photoanalgesia, as well as the targets involved in photoanalgesia, shedding light on its potential underlying mechanisms. Our aim is to provide a foundation to understand the mechanisms underlying CP and develop light as a novel analgesic treatment has its biological regulation principle for CP. This approach may provide an opportunity to drive the field towards future translational, clinical studies and support pain drug development. Keywords: chronic pain, light therapy, photoanalgesia, brain regions, molecular targets The eyes are important visual organs. The eyes can perceive light and convert stimuli to electrical signals. Besides their function in imaging, they also have many nonimaging functions, participating in processes such as the circadian rhythm, sleep quality, mood, and learning. 1–3 Recent studies also found that optical signals play an analgesic role. 4–7 Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. 8 It can be categorized as nociceptive (from tissue injury), neuropathic (from nerve injury), or nociplastic (from a sensitive nervous system). 9 Chronic pain (CP) is defined by the International Association for the Study of Pain as "persistent or recurrent pain lasting longer than 3 months". 10 Chronic pain is a very common disorder with an estimated global prevalence of about 20%. 11 The Global Burden of Disease Study 2019 revealed that CP was the greatest cause of years lived with disability worldwide. 12,13 At present, treatment of CP is not efficient, causes side effects, and may lead to drug tolerance, 14 which results in poor treatment outcomes and a heavy burden on patients. 9,15 Although various nonpharmacological treatment methods are available, including surgery, regional anesthesia, neuromodulation, and rehabilitation programs, pain is not reduced to a sufficient degree in many CP patients. Generally speaking, pain is rarely completely eliminated, and highly effective treatment methods are still lacking. 16 There is an urgent need to improve the pain treatment approaches without inducing adverse side effects. Light therapy has several advantages; it is noninvasive, convenient, and cost-effective. Exposure to light of specific wavelengths and intensities has shown to be effective in the management of various health conditions, such as cancers, 17 skin diseases, 18 sleep disorders, 19 and affective disorder. 20 Recently, light therapy has been used for various pain conditions, including chronic nonspecific low back pain, 21 fibromyalgia pain, 22 migraine headaches, 6 and neuropathic pain. 23 Based on this technique, optogenetic techniques have been developed that enable the control of cellular activity through ectopic expression of light-activated optogenetic proteins in genetically modified target cells. 24,25 In this review, we discuss how light can be used to induce analgesia, including the retinal photor -Abstract Truncated-
clinical neurology